SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aarti Pharmalabs formally inaugurates R&D Laboratory in Nerul

19 Dec 2023 Evaluate

Aarti Pharmalabs has formally inaugurated its new Research and Development (‘R&D’) Laboratory in Nerul, which has now become fully operationalised. This cutting-edge facility symbolizes the Company's commitment to advancing research and development in the pharmaceutical sector.

The company’s new R&D center is poised to enhance its Contract Development & Manufacturing (CDMO) business. The laboratory has cutting-edge technology based equipment and instruments including a section dedicated for flow chemistry. Focused on prioritizing safety and sustainability, the facility houses a Process Safety Laboratory equipped with advanced technology that meticulously studies both intended and unintended reactions, ensuring the highest standards of safety. 

The dedicated powder safety section further underscores APL's unwavering commitment to meticulous risk management. The facility boasts the latest designs of fume hoods, along with a state-of-the-art HVAC and Scrubbing system, to safeguard scientists and ensure a secure working environment. Embracing environmental consciousness, the laboratory is entirely paperless, utilizing e-books and the latest software to conduct experiments. This eco-friendly approach marks a significant step towards sustainability.

Aarti Pharmalabs (APL) (Formerly known as Aarti Organics) is a leading Indian manufacturer of Pharmaceuticals and Nutraceuticals with a global footprint. 


Aarti Pharmalabs Share Price

696.60 -2.85 (-0.41%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×